Form Type:  SC 13G
Filing Date:  7/11/2022 
CIK:  0001689548 
Address:  99 HIGH STREET, 30TH FLOOR 
City, State, Zip:  BOSTON, Massachusetts 02110 
Telephone:  617-300-8460 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
-0.02 (-1.03%)  
Trade Time: 
Nov 25  
Market Cap: 
Trade PRAX now with 

© 2022  
Description of Business
We are a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system, or CNS, disorders characterized by neuronal excitation-inhibition imbalance. Normal brain function requires a delicate balance of excitation and inhibition in neuronal circuits, which, when dysregulated, can lead to abnormal function and disease. We are applying insights from genetic epilepsies to both rare and more prevalent neurological and psychiatric disorders, using our understanding of shared biological targets and circuits in the brain. We apply a deliberate and pragmatic precision approach, leveraging a suite of translational tools including novel transgenic and predictive translational animal models and electrophysiology markers, to enable an efficient path to proof-of-concept in patients.
Register and access this filing in: